|
CP05a Inherited Bleeding Disorders including Haemophilia Management.pdf (PDF, 245Kb)
|
|
CP05b Inherited Bleeding Disorders including Haemophilia Management.pdf (PDF, 263Kb)
|
|
CP179, Sickle Cell Disorders, Thalassaemia Disorders and other Rare Hereditary Anaemias: all ages, Service Specification v1.0 (PDF, 530Kb)
|
|
PP167 Emicizumab as prophylaxis in people with congenital haemophilia A with Factor VIII inhibitors (all ages).pdf (PDF, 297Kb)
|
|
PP189 Emicizumab without factor VIII.pdf (PDF, 271Kb)
|
|
PP189 PP189 Emicizumab without factor VIII Policy v1.0.pdf (PDF, 79Kb)
|
|
Vonicog alfa for the treatment and prevention of bleeding in adults with von Willebrand disease, Policy Position Statement (PP215), May 2021 (PDF, 329Kb)
|